Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Klein

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Epilepsia|March 19, 2025
Cenobamate efficacy in specific populationsPavel Klein
Veterinary Journal (London, England : 1997)|July 4, 2007
Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled studyPavel Klein
CNS Drugs|June 19, 2021
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and BeyondWolfgang Löscher, Pavel Klein
Epilepsia|March 28, 2026
Ranking of antiseizure medications in a panel of focal seizure models predicts their comparative efficacy in clinical add-on trials in drug-resistant focal epilepsyWolfgang Löscher, Pavel Klein
Neuropharmacology|September 10, 2019
No prevention or cure of epilepsy as yetPavel Klein, Ivana Tyrlikova
Pharmacology & Therapeutics|July 3, 2021
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?Wolfgang Löscher, Pavel Klein
Advances in Therapy|May 29, 2024
Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with EpilepsyPavel Klein, Dimitrios Bourikas
Epilepsy & Behavior : E&B|February 16, 2005
Effect of ACTH-induced hypercortisolemia on the EEG in patients with stress-related epilepsyPavel Klein, Sanjiv Sahoo
Expert Review of Neurotherapeutics|August 9, 2017
Intravenous carbamazepine: a new formulation of a familiar drugPavel Klein, Dwain Tolbert
Epilepsy & Behavior : E&B|June 26, 2017
Prevention of epilepsy: Should we be avoiding clinical trials?Pavel Klein, Ivana Tyrlikova
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Epilepsia|March 19, 2025
Cenobamate efficacy in specific populationsPavel Klein
Veterinary Journal (London, England : 1997)|July 4, 2007
Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled studyPavel Klein
CNS Drugs|June 19, 2021
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and BeyondWolfgang Löscher, Pavel Klein
Epilepsia|March 28, 2026
Ranking of antiseizure medications in a panel of focal seizure models predicts their comparative efficacy in clinical add-on trials in drug-resistant focal epilepsyWolfgang Löscher, Pavel Klein
Neuropharmacology|September 10, 2019
No prevention or cure of epilepsy as yetPavel Klein, Ivana Tyrlikova
Pharmacology & Therapeutics|July 3, 2021
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?Wolfgang Löscher, Pavel Klein
Advances in Therapy|May 29, 2024
Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with EpilepsyPavel Klein, Dimitrios Bourikas
Epilepsy & Behavior : E&B|February 16, 2005
Effect of ACTH-induced hypercortisolemia on the EEG in patients with stress-related epilepsyPavel Klein, Sanjiv Sahoo
Expert Review of Neurotherapeutics|August 9, 2017
Intravenous carbamazepine: a new formulation of a familiar drugPavel Klein, Dwain Tolbert
Epilepsy & Behavior : E&B|June 26, 2017
Prevention of epilepsy: Should we be avoiding clinical trials?Pavel Klein, Ivana Tyrlikova
Pageof 12